login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INTENSITY THERAPEUTICS INC (INTS) Stock News
USA
-
Nasdaq
- NASDAQ:INTS -
US45828J1034
-
Common Stock
0.3993
USD
+0 (+0.76%)
Last: 11/28/2025, 7:39:38 PM
0.4001
USD
+0 (+0.2%)
After Hours:
11/28/2025, 7:39:38 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INTS Latest News, Press Relases and Analysis
All
Press Releases
17 days ago - By: Benzinga
- Mentions:
DERM
LPTX
CMND
ADIL
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
23 days ago - By: Intensity Therapeutics Inc.
Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
a month ago - By: Benzinga
- Mentions:
MNOV
KALA
EDSA
PHGE
...
12 Health Care Stocks Moving In Friday's After-Market Session
4 months ago - By: The Motley Fool
Intensity (INTS) Q2 Net Loss Drops 50%
a month ago - By: Intensity Therapeutics Inc.
Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock
a month ago - By: Stocktwits
- Mentions:
VXF
Why Is Retail Going Gaga Over INTS Stocks Today?
a month ago - By: Intensity Therapeutics Inc.
Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
3 months ago - By: Intensity Therapeutics Inc.
Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
3 months ago - By: Intensity Therapeutics Inc.
Intensity Therapeutics, Inc. to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
4 months ago - By: Intensity Therapeutics Inc.
Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
4 months ago - By: Intensity Therapeutics Inc.
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
4 months ago - By: Intensity Therapeutics Inc.
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025
Please enable JavaScript to continue using this application.